Skip to main content

BGI to Use Covaris' High-Throughput DNA Shearing Platform

Premium

China's BGI will adopt Covaris' high-throughput DNA shearing technology at several of its laboratories in China, Covaris said this week.

Under the deal, BGI will use Covaris' LE220 instrument and consumables as part of its library construction process for next-generation sequencing.

The LE220 is designed for high-throughput next-gen sequencing operations. Using Covaris' Adaptive Focused Acoustic, or AFA, technology, it can shear several DNA samples in parallel and accepts a variety of well plate formats.

For example, in a 96-well microplate, the instrument processes a row of eight samples in parallel, according to the firm.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.